The House of Lords Science and Technology Committee continues to take evidence for its inquiry into Life Sciences and the Industrial Strategy. Giving evidence is the Chief Executive designate of UK Research and Innovation (UKRI), Professor Sir Mark Walport.
Purpose of session
The Committee explores the role UKRI has in the implementation of the Life Sciences strategy and how it ensures the UK has the necessary skills base for its successful implementation.
Tuesday 12 December in Committee Room 4A, Palace of Westminster
- Professor Sir Mark Walport FRS, CEO designate, UK Research and Innovation (UKRI)
- The Industrial Strategy White Paper outlines a new UKRI 'Strategic Priorities Fund'. How do you foresee this working?
- Sir John Bell highlights the importance of the UK's science offer and the strong base of fundamental research in UK universities. Is there a risk that, with extra funding for innovation and applied research through the Industrial Strategy Challenge Fund, that fundamental research will be neglected?
- How will UKRI ensure that the necessary research infrastructure exists to support an uplift in research spending, in particular in the life sciences?
- Does UKRI and the Government have sufficient data on the UK’s international reputation in the science community to assess the impact of Brexit on that reputation?
Image: Parliamentary copyright